Form 4: Director Carmen Volkart Increases Stake in TCMD

Director Carmen B. Volkart acquired 6,521 shares of Tactile Systems Technology, Inc. (TCMD) through a restricted stock unit grant.

Summary

• Director Carmen B. Volkart was granted 6,521 restricted stock units (RSUs) on May 6, 2026.
• The transaction increases the director's total beneficial ownership to 44,219 shares of common stock.
• The shares were acquired at a price of $0, representing an equity-based compensation grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Director alignment with shareholder interests is strengthened through increased equity ownership.
• The grant reflects standard corporate governance practices for director compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The restricted stock units are scheduled to vest in full on the earlier of one year from the grant date or the date of the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that director equity grants are standard practice in the medical technology sector to ensure long-term alignment between board members and company performance.

Comparison to Industry Standards

• The grant of restricted stock units to non-employee directors is consistent with standard compensation packages for mid-cap medical device companies.
• The vesting schedule aligns with typical annual meeting cycles observed in the industry.

Stakeholder Impact

• Shareholders benefit from increased director 'skin in the game'.

Next Steps

• Vesting of the 6,521 restricted stock units on the earlier of May 6, 2027, or the 2027 annual meeting date.

Key Dates

Keywords

TCMD, Tactile Systems Technology, Form 4, Insider Trading, Director Compensation, Equity Grant